-
-
-
-
-
-
-
Piper Sandler Sees Sees a 'compelling buying opportunity' in Tenax Therapeutics (TENX)
-
-
-
-
-
-
-
Tenax Therapeutics (TENX) PT Raised to $25 at Guggenheim
-
-
-
-
-
-
-
Tenax Therapeutics (TENX) Misses Q2 EPS by 27c
-
-
-
-
-
-
-
Tenax Therapeutics (TENX) Appoints Gillian Andor Vice President, Clinical Operations
-
-
-
-
-
443,903 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

